deltatrials
Terminated PHASE2 INTERVENTIONAL 3-arm NCT00089414

Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives

The Treatment of Menstrually-Related Mood Disorders With Extended Versus Interrupted Oral Contraceptives

Sponsor: National Institute of Mental Health (NIMH)

Conditions Depression PMDD PMS Premenstrual Dysphoric Disorder Premenstrual Syndrome
Interventions CDB 2914 Ethinyl Estradiol/Drospirenone Placebo
Updated 13 times since 2017 Last updated: Jul 26, 2017 Started: Jul 31, 2004 Primary completion: Jun 30, 2010 Completion: Jun 30, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Informed by manufacturer that CDB-2914 crosses blood-brain barrier invalidating Arm #3 of protocol.

Other terminated trials from National Institute of Mental Health (NIMH)

See all terminations from National Institute of Mental Health (NIMH)

Other Depression trials with similar outcome

Browse all Depression trials

Listed as NCT00089414, this PHASE2 trial focuses on Depression and PMDD and remains terminated or withdrawn. Sponsored by National Institute of Mental Health (NIMH), it has been updated 13 times since 2004, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshot~Aug 2017 – ~Sep 2017 · 31 days · monthly snapshot~Sep 2017 – ~May 2018 · 8 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE2

  5. Dec 2021 — Dec 2022 [monthly]

    Terminated PHASE2

▶ Show 8 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE2

  2. Nov 2020 — Jan 2021 [monthly]

    Terminated PHASE2

  3. Jun 2018 — Nov 2020 [monthly]

    Terminated PHASE2

  4. May 2018 — Jun 2018 [monthly]

    Terminated PHASE2

  5. Sep 2017 — May 2018 [monthly]

    Terminated PHASE2

  6. Aug 2017 — Sep 2017 [monthly]

    Terminated PHASE2

  7. Feb 2017 — Aug 2017 [monthly]

    Terminated PHASE2

  8. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE2

    First recorded

Jul 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Mental Health (NIMH)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations